Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art
Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art have?
Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art has 167 citations in the OpenAlex counts ScholarIQ stores.
When was Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art published?
Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art has 2021 year in the ScholarIQ index.
What is the open-access status of Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art?
Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art has diamond oa status in the ScholarIQ index.
What is the DOI of Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art?
The DOI for Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art is on the source record.
What is the PMID of Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art?
The PMID for Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art is on the source record.
What is the OpenAlex record for Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art?
The OpenAlex for Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art is on the source record.